|
|
||||||||




Departments of
*
Immunology and
Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037;
National Center for Microscopy and Imaging Research, University of California at San Diego, La Jolla, CA 92093;
BD Pharmingen, San Diego, CA 92121; and
¶ Division of Molecular Medicine, La Jolla Institute of Molecular Medicine, San Diego, CA 92121
The present studies were undertaken to determine whether
neuronal subsets in normal brains constitutively express functionally
competent C5a receptors. In situ hybridization studies coupled with
immunohistochemical approaches revealed that most neurons in the
hippocampal formation, many pyramidal cortical neurons, and cerebellar
Purkinje neurons in normal human and murine brains constitutively
express C5a receptors. Neuronal C5a receptors bound C5a-coated
fluorescent microspheres, and primary rodent hippocampal neurons
responded to C5a with increased calcium fluxes via a
pertussis-sensitive, presumably Gi-coupled protein. Additional studies
with human neuroblastoma cells conducted to address the functional role
of C5a receptors revealed that C5a triggered rapid activation of
protein kinase C and activation and nuclear translocation of the
NF-
B transcription factor. In addition, C5a was found to be
mitogenic for undifferentiated human neuroblastoma cells, a novel
action for the C5aR. In contrast, C5a protected terminally
differentiated human neuroblastoma cells from toxicity mediated by the
amyloid A
peptide. Thus, normal rodent hippocampal neurons as well
as undifferentiated and differentiated human neuroblastoma cells
express functional C5a receptors. These results have implications for
understanding the role of neuronal C5aR receptors in normal neuronal
development, neuronal homeostasis, and neuroinflammatory conditions
such as Alzheimers disease.
This article has been cited by other articles:
![]() |
S. N. Patel, J. Berghout, F. E. Lovegrove, K. Ayi, A. Conroy, L. Serghides, G. Min-oo, D. C. Gowda, J. V. Sarma, D. Rittirsch, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria J. Exp. Med., May 12, 2008; 205(5): 1133 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Martin and B. K. Martin Characterization of the Murine C3a Receptor Enhancer-Promoter: Expression Control by an Activator Protein 1 Sequence and an Ets-Like Site J. Immunol., September 1, 2005; 175(5): 3123 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benard, B. J. Gonzalez, M.-T. Schouft, A. Falluel-Morel, D. Vaudry, P. Chan, H. Vaudry, and M. Fontaine Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation: NEUROPROTECTIVE EFFECT OF C5a AGAINST APOPTOTIC CELL DEATH J. Biol. Chem., October 15, 2004; 279(42): 43487 - 43496. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rawal and M. K. Pangburn Formation of High Affinity C5 Convertase of the Classical Pathway of Complement J. Biol. Chem., October 3, 2003; 278(40): 38476 - 38483. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Farkas, M. Takahashi, A. Fukuda, N. Yamamoto, H. Akatsu, L. Baranyi, H. Tateyama, T. Yamamoto, N. Okada, and H. Okada Complement C5a Receptor-Mediated Signaling May Be Involved in Neurodegeneration in Alzheimer's Disease J. Immunol., June 1, 2003; 170(11): 5764 - 5771. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kimura, M. Madhavan, M. K. Call, W. Santiago, P. A. Tsonis, J. D. Lambris, and K. Del Rio-Tsonis Expression of Complement 3 and Complement 5 in Newt Limb and Lens Regeneration J. Immunol., March 1, 2003; 170(5): 2331 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Cain and P. N. Monk The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 J. Biol. Chem., February 22, 2002; 277(9): 7165 - 7169. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |